Phase 3 data on rademikibart in moderate-to-severe atopic dermatitis (AD) have been released from the AAD late-Breaking research session.
Cheng Zhou, MD
Advertisement
Cheng Zhou, MD, is a professor and chair of the department of dermatology at Peking University People`s Hospital in China.
Articles by Cheng Zhou, MD
Advertisement